Anhydrous Tacrolimus,
Anhydrous, Tacrolimus,
FK 506,
FK-506,
FK506,
FR 900506,
FR-900506,
FR900506,
Prograf,
Prograft,
Tacrolimus,
Tacrolimus Anhydrous,
Tacrolimus, Anhydrous,
tacrolimus,
104987-11-3,
Prograf,
Protopic,
Fujimycin,
Tsukubaenolide,
FK506,
Tacrolimus anhydrous,
Modigraf,
Protopy,
LCP-Tacro,
Fk-506,
FK 506,
Anhydrous Tacrolimus,
tacrolimus (fk506),
FR-900506,
Advagraf,
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN,
UNII-Y5L2157C4J,
K506,
Astagraf XL,
(-)-FK 506,
Prograf (TN),
FR900506,
Tacarolimus,
CHEMBL269732,
CHEBI:61049,
FR 900506,
Y5L2157C4J,
MFCD11045918,
FK5,
109581-93-3,
Tacrolimus (anhydrous),
NCGC00163470-03,
Prograft,
Tacrolimus [USAN],
CCRIS 7124,
Avagraf,
Envarsus,
Graceptor,
L 679934,
Envarsus XR,
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)tetrone,
Tacrolimus (INN),
FK-506 (Tacrolimus),
Tacrolimus, anhydrous,
SR-05000001879,
Tacrolimus [USAN:INN],
Hecoria,
Talymus,
HSDB 8195,
FK-506/Tacrolimus,
PubChem18875,
AC1L9IBU,
SCHEMBL3088,
DSSTox_CID_26354,
DSSTox_RID_81557,
DSSTox_GSID_46354,
BSPBio_001279,
CHEMBL66247,
L-679934,
GTPL6784,
DTXSID5046354,
CHEBI:93221,
HMS503O21,
QJJXYPPXXYFBGM-LFZNUXCKSA-N,
C44H69NO12,
HMS1792O21,
HMS1990O21,
HMS2093M19,
HMS3403O21,
Pharmakon1600-01503968,
15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxycyclohexyl)-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-, (3S-(3R*(E(1S*,3S*,4S*)),4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*))-,
EX-A1677,
Tox21_112056,
ABP000474,
BDBM50030448,
BDBM50079777,
LMPK04000003,
NSC758659,
s5003,
AKOS005145901,
ZINC169289411,
AC-1182,
AM81227,
AT-2441,
CS-1507,
DB00864,
NSC-758659,
IDI1_001040,
NCGC00163470-01,
NCGC00163470-02,
NCGC00163470-04,
NCGC00163470-05,
NCGC00163470-06,
NCGC00163470-07,
BC205151,
HY-13756,
SC-13591,
Fujimycin|||FK-506|||FR-900506,
SBI-0052894.P002,
AB0012538,
CAS-104987-11-3,
FT-0082660,
M2258,
C01375,
D08556,
EN300-221601,
W-1246,
AB01209746-01,
AB01209746_03,
581T933,
Q-201775,
SR-05000001879-1,
SR-05000001879-2,
SR-05000001879-5,
BRD-K35452788-001-02-1,
BRD-K69608737-001-03-7,
BRD-K69608737-001-10-2,
[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-,
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,,
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone,
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-prop-2-en-1-yl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone,
(E)-(1R,9S,12S,13R,14R,21S,23S,24R,25S,27R)-17-Allyl-1,14-dihydroxy-12-[(E)-2-((3R,4R)-4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-vinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-aza-tricyclo[22.3.1.0*4,9*]octacos-18-ene-2,3,10,16-tetraone,
15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyc,
4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-heptadecahydro-5,19-dihydroxy-3-,
dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-,(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-,
lohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-,
Tacrolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material,
TacroBell,
Tacrolimus hydrate,
Advagraf (TN),
Protopic (TN),
Anhydrous, Tacrolimus,
Tacrolimus (Prograf),
D06OMK,
TACROLIMUS MONOHYDRATE,
Tacrolimus [USAN:BAN:INN],
CID445643,
C44-H69-N-O12,
ACN-036876,
CB10275,
Tacrolimus, 98.5% - 10MG 10mg,
B2143,
D016559,
15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
15 19-Epoxy-3H-pyrido[2 1-c][1 4]oxaazacyclotricosine-1 7 20 21(4H 23H)-tetrone 5 6 8 11 12 13 14 15 16 17 18 19 24 25 26 26a-hexadecahydro-5 19-dihydroxy-3-[(1E)-2-[(1R 3R 4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14 16-dimethoxy-4 10 12 18-tet,
15 19-Epoxy-3H-pyrido[2 1-c][1 4]oxaazacyclotricosine-1 7 20 21(4H 23H)-tetrone 5 6 8 11 12 13 14 15 16 17 18 19 24 25 26 26a-hexadecahydro-5 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14 16-dimethoxy-4 10 12 18-tetramethyl-8-(2-pr,
15,19-epoxi-3h-pirido[2,1-c][1,4]oxaazaciclotricosina-1,7,20,21(4h,23h)-tetrona, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahidro-5,19-dihidroxi-3-[(1e)-2-[(1r,3r,4r)-4-hidroxi-3-metoxiciclohexil]-1-metiletenil]-14,16-dimetoxi-4,10,12,18-tetram,
15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-, monohydrate, (3S-(3R*(E(1S*,3S*,4S*)),4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*))-,
TAC,